The Oncology Institute, Inc. (NASDAQ: TOI) reported Q3 EPS of ($0.18), $0.11 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $99.9 million versus the consensus estimate of $107.54 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.